<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2018-97-5-396-398</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-558</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОБЛЕМНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROBLEM-SOLVING ARTICLES</subject></subj-group></article-categories><title-group><article-title>Научные предпосылки для создания криоконсервации микроэкологических ресурсов человека</article-title><trans-title-group xml:lang="en"><trans-title>The scientific backgrounds for the creation of a microecological cryopreservation of human resources</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шендеров</surname><given-names>Б. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shenderov</surname><given-names>Boris A.</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, Ph.D., DSci., main researcher of the Laboratory of Sanitary Bacteriology and Parasitology of the Centre for Strategic Planning and Management of Biomedical Health Risks, Moscow, 119992, Russian Federation.</p><p>e-mail: shenderof@yandex.ru</p></bio><email xlink:type="simple">shenderof@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юдин</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Yudin</surname><given-names>S. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шевырева</surname><given-names>Марина Павловна</given-names></name><name name-style="western" xml:lang="en"><surname>Shevyreva</surname><given-names>M. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, проф., зам. директора по научной работе ФГБУ «ЦСП» Минздрава России.</p><p>e-mail: shevirevamp@yandex.ru</p></bio><email xlink:type="simple">shevirevamp@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойко</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Boyko</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «Центр стратегического планирования и управления медико-биологическими рисками здоровью» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Centre for Strategic Planning and Management of Biomedical Health Risks<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБУ «Центр стратегического планирования и управления медико-биологическими рисками здоровью» Минздрава России; ФГАОУ ВО Первый московский государственный медицинский университет им. И.М. Сеченова (Сеченовский университет) Минздрава России<country>Россия</country></aff><aff xml:lang="en">Centre for Strategic Planning and Management of Biomedical Health Risks; I.M. Sechenov First Moscow State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2020</year></pub-date><volume>97</volume><issue>5</issue><fpage>396</fpage><lpage>398</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шендеров Б.А., Юдин С.М., Шевырева М.П., Бойко Е.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Шендеров Б.А., Юдин С.М., Шевырева М.П., Бойко Е.А.</copyright-holder><copyright-holder xml:lang="en">Shenderov B.A., Yudin S.M., Shevyreva M.P., Boyko E.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/558">https://www.rjhas.ru/jour/article/view/558</self-uri><abstract><p>Антропогенные воздействия — физические, химические и биологические — на живые организмы объектов окружающей среды ведут к глубоким структурным и функциональным нарушениям и прежде всего в эволюционно сложившихся микробиоценозах человека. Это нередко сопровождается ухудшением его здоровья, увеличением риска инфекционных, хронических метаболических и психических заболеваний, что, в конечном счёте, может поставить под вопрос не только сохранение на нашей планете человека, но и всего существующего разнообразия живых организмов. Разработка криобиотехнологий и создание криобанков различной направленности является общей мировой тенденцией развития биологических, медицинских, сельскохозяйственных, экологических наук. Преимуществом предлагаемого приёма криоконсервирования симбиотических микробиоценозов является то, что хранение биоматериалов, взятых от людей, будет осуществляться в атмосфере жидкого азота (-196 °С) для длительного хранения. Фундаментально-прикладные исследования по криоконсервации микробиоты различных биотопов человека имеют социальную направленность, поскольку связаны непосредственно с экологией человека и здоровьем нации.</p></abstract><trans-abstract xml:lang="en"><p>Anthropogenic physical, chemical, and biological impacts of objects on living organisms in the environment lead to profound structural and functional disorders primarily in the evolutionary current microbiocenosеs of a human. This is often accompanied by a deterioration in his health, an increase in the risk of infectious, chronic metabolic and mental diseases, which eventually can put a question for not only the preservation on our planet but also the entire existing diversity of living organisms. The development of cryobiotechnology and the creation of cryobanks of different directions is a common global trend in the development of Biological, Medical, Agricultural and Environmental Sciences. The advantage of the proposed technique of cryopreservation of symbiotic microbial associations is the storage of the biomaterials taken from the people will be carried out in an atmosphere of liquid nitrogen (-196°C) for the long-term storage. Fundamental and applied research on cryopreservation of microbiota of different human biotopes has a social orientation because they are directly related to human ecology and health of the nation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>микробиота</kwd><kwd>криобиотехнологии</kwd><kwd>криобанк</kwd><kwd>симбиотическая микробиота</kwd><kwd>микробиоценозы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>microbiota</kwd><kwd>cryobiotechnolo gy</kwd><kwd>cryobank</kwd><kwd>symbiotic microbiota</kwd><kwd>microbiocenoses</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шендеров Б.А. Микробная экология человека и ее роль в поддержании здоровья. Метаморфозы. 2014(3): 72-80</mixed-citation><mixed-citation xml:lang="en">Shenderov B.A. Microbial ecology of man and its role in maintaining health. Metamorphoses. 2014(3): 72-80.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Khachatrian R., Khachatrian A. Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men. US Patent 6428783 C12N 1/04, 2002</mixed-citation><mixed-citation xml:lang="en">Khachatrian R., Khachatrian A. Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men. US Patent 6428783 C12N 1/04, 2002</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Borody T., Warren E., Leis S., Surace R., Ashman O., Siarakas S. Bacteriotherapy using fecal flora: toping with human motions. J. Clin. Gastroenterol. 2004; 38(6): 475-83.</mixed-citation><mixed-citation xml:lang="en">Borody T., Warren E., Leis S., Surace R., Ashman O., Siarakas S. Bacteriotherapy using fecal flora: toping with human motions. J. Clin. Gastroenterol. 2004; 38(6): 475-83.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Debast S.B, Bauer M.P, Kuijper E.J. On behalf of the Committee. European Society of Clinical Microbiology and Infectious Diseases: update for the treatment guidance document for Clostridium difficult infection. Clin Microbiol Infect. 2014; 20 (Supply 2): 1-26.</mixed-citation><mixed-citation xml:lang="en">Debast S.B, Bauer M.P, Kuijper E.J. On behalf of the Committee. European Society of Clinical Microbiology and Infectious Diseases: update for the treatment guidance document for Clostridium difficult infection. Clin Microbiol Infect. 2014; 20 (Supply 2): 1-26.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bakken J.S. Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations. Microb. Ecol. Health Dis. 2015, 26: 27657.</mixed-citation><mixed-citation xml:lang="en">Bakken J.S. Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations. Microb. Ecol. Health Dis. 2015, 26: 27657.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Carlucci C., Petrof E.O., Allen-Vercoe E. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile infection, Ulcerative Colitis and Obesity. EBioMedicine. 2016. http://dx.doi.org/10.1016/J.ebiom.2016.09.029</mixed-citation><mixed-citation xml:lang="en">Carlucci C., Petrof E.O., Allen-Vercoe E. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile infection, Ulcerative Colitis and Obesity. EBioMedicine. 2016. https://doi.org/10.1016/J.ebiom.2016.09.029</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hyun Ho Choi, Young-Seok Cho. Fecal Microbiota translation: Current Applications, Effectiveness, and Future Perspectives. Clin. Endosc. 2016; 49: 257-265.</mixed-citation><mixed-citation xml:lang="en">Hyun Ho Choi, Young-Seok Cho. Fecal Microbiota translation: Current Applications, Effectiveness, and Future Perspectives. Clin. Endosc. 2016; 49: 257-265.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nibali L., Henderson B. The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016 John Wiley &amp; Sons, Inc. New Jersey, USA, 520 pages.</mixed-citation><mixed-citation xml:lang="en">Nibali L., Henderson B. The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016 John Wiley &amp; Sons, Inc. New Jersey, USA, 520 pages.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fak F. The gut microbiota: a predisposing factor in vanity, diabetes and atherosclerosis. Chapter 23. In: The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016. John Wiley &amp; Sons, Inc. New Jersey, USA; 351-359.</mixed-citation><mixed-citation xml:lang="en">Fak F. The gut microbiota: a predisposing factor in vanity, diabetes and atherosclerosis. Chapter 23. In: The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016. John Wiley &amp; Sons, Inc. New Jersey, USA; 351-359.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lo Vecchio A., Guarino A. The microbiota as target for therapeutic intervention in pediatric intestinal diseases. Chapter 31. In: The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016. John Wiley &amp; Sons, Inc. New Jersey, USA; 483-496.</mixed-citation><mixed-citation xml:lang="en">Lo Vecchio A., Guarino A. The microbiota as target for therapeutic intervention in pediatric intestinal diseases. Chapter 31. In: The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016. John Wiley &amp; Sons, Inc. New Jersey, USA; 483-496.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bruzzese E., Buccigrossi V., Ranucci G., Guarino A. Microbial therapy for cystic fibrosis. Chapter 32. In: The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016. John Wiley &amp; Sons, Inc. New Jersey, USA; 497-506.</mixed-citation><mixed-citation xml:lang="en">Bruzzese E., Buccigrossi V., Ranucci G., Guarino A. Microbial therapy for cystic fibrosis. Chapter 32. In: The Human Microbiota and Chronic Disease: Dysbiosis as a cause of Human Pathology. First Edition. 2016. John Wiley &amp; Sons, Inc. New Jersey, USA; 497-506.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kazerouni A., Burgess J., Burns L.J., Wein L.M. Optimal screening and donor management in a public stool bank. Microbiome 2015; 3: 75. doi 10.1186/s40168-015-0140-3</mixed-citation><mixed-citation xml:lang="en">Kazerouni A., Burgess J., Burns L.J., Wein L.M. Optimal screening and donor management in a public stool bank. Microbiome 2015; 3: 75. doi 10.1186/s40168-015-0140-3</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Шендеров Б.А., Гахова Э.Н., Каурова С.А., Утешев В.К., Шишова Р.В. Криобанки природных сммбиотических микробиоценозов и их значение в медицине и биотехнологии. Биофизика живой клетки. 2014(10): 221-223.</mixed-citation><mixed-citation xml:lang="en">Shenderov B.A., gakhova E.N., kaurova S.A., Uteshev V.K., Shishova R.V. Cryobanks natural simbioticheskoi of microbial associations and their importance in medicine and biotechnology. Biophysics of living cells. 2014(10): 221-223.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Безродный С.Л., Шендеров Б.А. Кишечная микробиота как источник новых биомаркеров старения. Вестник восстановительной медицины. 2015(2): 40-47.</mixed-citation><mixed-citation xml:lang="en">Bezrodny S.L., Shenderov B.A. Intestinal microbiota as a source of new biomarkers of aging. Journal of restorative medicine &amp; rehabilitation. 2015(2): 40-47.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Шендеров Б.А. Микроэкологическая эпигенетика стресса, заболеваний, здоровья и долголетия. Вестник восстановительной медицины. 2016(1): 21-28.</mixed-citation><mixed-citation xml:lang="en">Shenderov B.A. Microecological epigenetics of stress, diseases, health and longevity. Journal of restorative medicine &amp; rehabilitation. 2016(1): 21-28.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
